Semaglutide boosts walking ability in diabetes patients with peripheral artery disease, clinical trial finds
Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...
Stem cell infusion timing can prevent acute graft-versus-host disease
A research team has identified the impact of stem cell infusion timing on the incidence and severity of acute ...